Ad
AKER - Akers Biosciences Stock Trading
About | Akers Biosciences Inc. (NASDAQ:AKER)
Not available
Quote | Akers Biosciences Inc. (NASDAQ:AKER)
| Last: | $2.47 |
|---|---|
| Change Percent: | -9.52% |
| Open: | $2.65 |
| Close: | $2.47 |
| High: | $3.04 |
| Low: | $2.4044 |
| Volume: | 1,582,060 |
| Last Trade Date Time: | 04/16/2021 04:56:39 pm |
News | Akers Biosciences Inc. (NASDAQ:AKER)
-
FORT WORTH, Texas, April 29, 2021 (GLOBE NEWSWIRE) -- Contango Oil & Gas Company (NYSE American: MCF) (“Contango” or the “Company”) today announced the appointment of Karen Simon and Janet Pasque to its Board of Directors (the “Board”) effective...
-
Shares to commence trading on the Nasdaq Capital Market on April 19, 2021 under the new ticker symbol " MYMD " Upon Closing, the Combined Company will focus on developing and commercializing novel immunotherapy pipeline assets, including its lead molecule MYMD-1 ...
Message Board Posts | Akers Biosciences Inc. (NASDAQ:AKER)
| Subject | By | Source | When |
|---|---|---|---|
| $MYMD-1 TO THE RESCUE !!!!! | SeanVan | investorshub | 05/04/2021 9:37:30 PM |
| https://investorshub.advfn.com/$MYMD-$MYMD-39405/ | knuts4oe | investorshub | 04/19/2021 6:07:13 PM |
| Seasoned executive team with a track record of | SeanVan | investorshub | 04/19/2021 5:13:47 PM |
| MyMD Pharmaceuticals Begins Trading on Nasdaq.. | SeanVan | investorshub | 04/19/2021 5:13:34 PM |
| DONE | MikeSailMikeSail | investorshub | 04/19/2021 4:21:23 PM |
Akers Biosciences Inc. Company Name:
AKER Stock Symbol:
NASDAQ Market:
Akers Biosciences Inc. Website:
Ad
-
FORT WORTH, Texas, April 29, 2021 (GLOBE NEWSWIRE) -- Contango Oil & Gas Company (NYSE American: MCF) (“Contango” or the “Company”) today announced the appointment of Karen Simon and Janet Pasque to its Board of Directors (the “Board”) effective...
-
Shares to commence trading on the Nasdaq Capital Market on April 19, 2021 under the new ticker symbol " MYMD " Upon Closing, the Combined Company will focus on developing and commercializing novel immunotherapy pipeline assets, including its lead molecule MYMD-1 ...
-
Akers Biosciences, Inc. (NASDAQ: AKER), today announced that its proposed merger partner MyMD Pharmaceuticals, Inc. (“MyMD”), a clinical stage pharmaceutical company committed to extending health lifespan and treating immune mediated illnesses, has reached an agreement...